# A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

> **NCT00004585** · PHASE4 · COMPLETED · sponsor: **Glaxo Wellcome** · enrollment: 40 (—)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Abacavir sulfate, Lamivudine and Zidovudine
- **DRUG:** Lamivudine/Zidovudine
- **DRUG:** Abacavir sulfate
- **DRUG:** Efavirenz

## Key facts

- **NCT ID:** NCT00004585
- **Lead sponsor:** Glaxo Wellcome
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-10
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00004585

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00004585, "A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00004585. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*